Ece Bayram1, Dennis W Dickson2, Stephen G Reich3, Irene Litvan1. 1. Department of Neurosciences, Parkinson and Other Movement Disorders Center University of California San Diego La Jolla California USA. 2. Department of Neuroscience Mayo Clinic Jacksonville Florida USA. 3. Department of Neurology University of Maryland Baltimore Maryland USA.
Abstract
BACKGROUND: Corticobasal degeneration (CBD) can present with various clinical phenotypes including Richardson's syndrome (RS). Although neuropathological examination can differentiate CBD and progressive supranuclear palsy (PSP) pathologies, no clinical or imaging findings can differentiate CBD from other pathologies when a patient presents with a variant type of CBD. As these various phenotypes are associated with non-CBD pathologies, clinical diagnostic accuracy can be low for such patients. OBJECTIVES: To present clinical features of two cases with symptom progression in line with PSP-RS, who were diagnosed with CBD based on neuropathological examination. METHODS: Baseline, follow up examinations, and detailed neuropathological examinations of two CBD cases presenting and progressing in line with probable PSP-RS are demonstrated. RESULTS: The two cases clinically diagnosed as probable PSP-RS were shown to have CBD upon neuropathological examination, which is the gold standard for diagnosis of both PSP and CBD. CONCLUSIONS: These cases emphasize the importance of neuropathology for the definite diagnosis, and stress the need for distinctive markers to increase the reliability of clinical diagnosis before death.
BACKGROUND: Corticobasal degeneration (CBD) can present with various clinical phenotypes including Richardson's syndrome (RS). Although neuropathological examination can differentiate CBD and progressive supranuclear palsy (PSP) pathologies, no clinical or imaging findings can differentiate CBD from other pathologies when a patient presents with a variant type of CBD. As these various phenotypes are associated with non-CBD pathologies, clinical diagnostic accuracy can be low for such patients. OBJECTIVES: To present clinical features of two cases with symptom progression in line with PSP-RS, who were diagnosed with CBD based on neuropathological examination. METHODS: Baseline, follow up examinations, and detailed neuropathological examinations of two CBD cases presenting and progressing in line with probable PSP-RS are demonstrated. RESULTS: The two cases clinically diagnosed as probable PSP-RS were shown to have CBD upon neuropathological examination, which is the gold standard for diagnosis of both PSP and CBD. CONCLUSIONS: These cases emphasize the importance of neuropathology for the definite diagnosis, and stress the need for distinctive markers to increase the reliability of clinical diagnosis before death.
Authors: Helen Ling; Sean S O'Sullivan; Janice L Holton; Tamas Revesz; Luke A Massey; David R Williams; Dominic C Paviour; Andrew J Lees Journal: Brain Date: 2010-07 Impact factor: 13.501
Authors: Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller Journal: Ann Neurol Date: 2011-08 Impact factor: 10.422
Authors: Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs Journal: Mov Disord Date: 2019-02-06 Impact factor: 10.338
Authors: Keith A Josephs; Jennifer L Whitwell; Pawel Tacik; Joseph R Duffy; Matthew L Senjem; Nirubol Tosakulwong; Clifford R Jack; Val Lowe; Dennis W Dickson; Melissa E Murray Journal: Acta Neuropathol Date: 2016-09-19 Impact factor: 17.088
Authors: Marta Marquié; Marc D Normandin; Avery C Meltzer; Michael Siao Tick Chong; Nicolas V Andrea; Alejandro Antón-Fernández; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik Debnath; Elizabeth A Bien; Charles R Vanderburg; Isabel Costantino; Sara Makaretz; Sarah L DeVos; Derek H Oakley; Stephen N Gomperts; John H Growdon; Kimiko Domoto-Reilly; Diane Lucente; Bradford C Dickerson; Matthew P Frosch; Bradley T Hyman; Keith A Johnson; Teresa Gómez-Isla Journal: Ann Neurol Date: 2017-01 Impact factor: 10.422
Authors: Connie Luk; Yaroslau Compta; Nadia Magdalinou; Maria José Martí; Geshanthi Hondhamuni; Henrik Zetterberg; Kaj Blennow; Radu Constantinescu; Yolande Pijnenburg; Brit Mollenhauer; Claudia Trenkwalder; John Van Swieten; Wan Zheng Chiu; Barbara Borroni; Ana Cámara; Perdita Cheshire; David R Williams; Andrew J Lees; Rohan de Silva Journal: J Neurochem Date: 2012-09-03 Impact factor: 5.372
Authors: Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan Journal: Mov Disord Date: 2017-05-03 Impact factor: 10.338
Authors: Matthias Brendel; Sonja Schönecker; Günter Höglinger; Simon Lindner; Joachim Havla; Janusch Blautzik; Julia Sauerbeck; Guido Rohrer; Christian Zach; Franziska Vettermann; Anthony E Lang; Lawrence Golbe; Georg Nübling; Peter Bartenstein; Katsutoshi Furukawa; Aiko Ishiki; Kai Bötzel; Adrian Danek; Nobuyuki Okamura; Johannes Levin; Axel Rominger Journal: Front Aging Neurosci Date: 2018-01-17 Impact factor: 5.750
Authors: Piotr Alster; Natalia Madetko; Bartosz Migda; Michał Nieciecki; Michał Kutyłowski; Leszek Królicki; Andrzej Friedman Journal: Diagnostics (Basel) Date: 2022-07-09
Authors: Marina Picillo; Maria Francesca Tepedino; Filomena Abate; Sara Ponticorvo; Roberto Erro; Sofia Cuoco; Nevra Oksuz; Gianfranco Di Salle; Francesco Di Salle; Fabrizio Esposito; Maria Teresa Pellecchia; Renzo Manara; Paolo Barone Journal: Neurol Sci Date: 2022-02-01 Impact factor: 3.830